Belatacept Therapy for the Failing Renal Allograft
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Belatacept (Primary) ; Ciclosporin; Mycophenolate mofetil; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 01 Dec 2021 Primary endpoint (Number of Participants With Donor-specific Antibody Formation) has been met, as per results published in the Transplantation.
- 01 Dec 2021 Results assessing efficacy and safety of belatacept in kidney transplant recipients with failed allografts for the prevention of humoral sensitization, published in the Transplantation.
- 08 Jan 2020 Status changed from active, no longer recruiting to completed.